Ovestin (Estriol)

Ovestin is an estrogen medication that acts on hormone‑responsive pathways, particularly in women’s health.

• Menopausal symptoms: alleviates hot flashes, night sweats and vaginal dryness.
• Vaginal atrophy: improves mucosal integrity and reduces discomfort.
• Osteoporosis prevention: contributes to bone mineral density maintenance in post‑menopausal women.

• Estriol binds to estrogen receptors (ERα and ERβ) in target tissues, producing a weaker estrogenic stimulus compared with estradiol. The receptor activation modulates gene transcription involved in the maintenance of the urogenital tract, bone metabolism and thermoregulatory centers, thereby correcting estrogen deficiency effects.

Adverse reactions to estriol are generally mild and dose‑dependent.

Common Side Effects

• Headache: mild, transient headache may occur.
• Nausea: occasional stomach upset or nausea.
• Breast tenderness: mild swelling or tenderness of breast tissue.
• Vaginal spotting: light spotting or breakthrough bleeding.
• Fluid retention: mild peripheral edema.
• Mood changes: slight irritability or mood swings.

Serious or Rare Side Effects

• Thromboembolic events: deep vein thrombosis or pulmonary embolism.
• Endometrial hyperplasia: abnormal thickening of the uterine lining.
• Liver dysfunction: elevated liver enzymes or hepatitis.
• Allergic reactions: rash, itching, swelling or anaphylaxis.
• Hormone‑dependent tumor growth: potential stimulation of estrogen‑sensitive cancers.

When prescribing estriol, clinicians should consider patient history and monitor for specific risks.

• Contraindication: do not use in known estrogen‑dependent malignancies.
• Cardiovascular risk: assess history of thrombosis or stroke before initiating therapy.
• Liver function: evaluate hepatic impairment and adjust use accordingly.
• Bone health: monitor bone mineral density in long‑term therapy.
• Drug interactions: review concomitant medications that affect estrogen metabolism.
• Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture and light.

Estriol may interact with several drug classes, requiring attention to dosage and monitoring.

Major Interactions (Avoid)

• Anticoagulants: may increase bleeding risk.
• Hormonal contraceptives: additive estrogenic effects can raise thrombotic risk.
• Certain antiepileptics (e.g., carbamazepine): may reduce estriol plasma levels.

Moderate Interactions (Monitor Closely)

• Selective serotonin reuptake inhibitors (SSRIs): may alter estrogen metabolism.
• Statins: potential for altered lipid profile monitoring.
• Thyroid hormones: estriol can affect thyroid‑binding globulin levels.